<SEC-DOCUMENT>0001493152-26-027865.txt : 20260609
<SEC-HEADER>0001493152-26-027865.hdr.sgml : 20260609
<ACCEPTANCE-DATETIME>20260609090001
ACCESSION NUMBER:		0001493152-26-027865
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20260609
FILED AS OF DATE:		20260609
DATE AS OF CHANGE:		20260609

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alps Group Inc
		CENTRAL INDEX KEY:			0002025774
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-HEALTH SERVICES [8000]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42915
		FILM NUMBER:		261074722

	BUSINESS ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		UNIT E-18-01 & E-18-02, LEVEL 18,
		STREET 2:		ICON TOWER (EAST), NO.1,JALAN 1/68F,
		CITY:			KUALA LUMPUR
		PROVINCE COUNTRY:   	N8
		BUSINESS PHONE:		60321631113

	MAIL ADDRESS:	
		ADDRESS IS A NON US LOCATION: 	YES
		STREET 1:		UNIT E-18-01 & E-18-02, LEVEL 18,
		STREET 2:		ICON TOWER (EAST), NO.1,JALAN 1/68F,
		CITY:			KUALA LUMPUR
		PROVINCE COUNTRY:   	N8

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Alps Global Holding Pubco
		DATE OF NAME CHANGE:	20240604
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6-k.htm
<DESCRIPTION>6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>UNITED
STATES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>SECURITIES
AND EXCHANGE COMMISSION</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 12pt"><B>Washington,
D.C. 20549</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>FORM
6-K</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>REPORT
OF FOREIGN PRIVATE ISSUER</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>PURSUANT
TO RULE 13a-16 OR 15d-16</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>UNDER
THE SECURITIES EXCHANGE ACT OF 1934</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>For
the month of June 2026</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Commission
File Number: 001-42915</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 18pt"><B>Alps
Group Inc</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Registrant&rsquo;s
Name)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Unit
E-18-01 &amp; E-18-02, Level 18, Icon Tower (East)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>No.
1, Jalan 1/68F, Jalan Tun Razak</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>50400
Kuala Lumpur</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Wilayah
Persekutuan, Malaysia</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>(Address
of Principal Executive Offices)</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Form
20-F &#9746; Form 40-F &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): &#9744;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 4pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Information
Contained in this Form 6-K Report</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attached
hereto as Exhibit 99.1 is a press release dated June 9, 2026 issued by Alps Group Inc (the &ldquo;Company&rdquo;), announcing that its
subsidiary, MyGenome Sdn. Bhd., has received accreditation for Whole Genome Sequencing under MS ISO 15189:2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exhibits</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.5in; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
    No.</B></FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 0.1in; padding-bottom: 1pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Description</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; background-color: white">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">99.1</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex99-1.htm">Press Release dated June 9, 2026</A></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>SIGNATURES</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 36.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</FONT></P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alps
    Group Inc</B></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 45%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
    June 9, 2026</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; border-bottom: black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>/s/
    Dr. Tham Seng Kong</I></FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:
    </FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.
    Tham Seng Kong</FONT></TD></TR>
  <TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
    Executive Officer and Director</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex99-1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
99.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 90px; width: 200px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Alps
Group Inc Expands MyGenome Accreditation to Include Whole Genome Sequencing Under MS ISO 15189:2022</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><I>MyGenome
Joins a Limited Number of Southeast Asian Laboratories Delivering WGS Under Internationally Recognized Clinical Standards, Strengthening
its Position in Southeast Asian Genomics</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>KUALA
LUMPUR, Malaysia &ndash; June 9, 2026</B> &ndash; Alps Group Inc (&ldquo;Alps&rdquo; or &ldquo;the Company&rdquo;) (Nasdaq: ALPS), an
integrated biotechnology platform headquartered in Malaysia, today announced that its subsidiary, MyGenome Sdn. Bhd. (&ldquo;MyGenome&rdquo;),
has received accreditation for its Whole Genome Sequencing (&ldquo;WGS&rdquo;) under MS ISO 15189:2022.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">MS
ISO 15189:2022 is an internationally recognized clinical standard that sets rigorous requirements for quality and competence in medical
laboratories. Unlike targeted genetic panels, WGS examines a patient&rsquo;s complete DNA sequence, making accreditation at this level
a meaningful technical distinction. The expanded accreditation confirms that MyGenome&rsquo;s genomic data meets the accuracy, reproducibility,
and reliability benchmarks required for clinical use, healthcare adoption, and integration into research programs, positioning MyGenome
among a select group of genomics laboratories in Southeast Asia operating WGS under this standard.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
milestone provides additional validation for institutional partners and investors alike, demonstrating that MyGenome&rsquo;s WGS process
meets the compliance-grade infrastructure required for adoption in clinical and research settings, broadening Alps&rsquo; addressable
market to include government-linked healthcare programs, cross-border partnerships, and institutional clients across the region.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Expanding
our MS ISO 15189:2022 accreditation scope to include Whole Genome Sequencing is a meaningful validation of the clinical infrastructure
we are building,&rdquo; said Dr. Tham Seng Kong, Executive Director and Group Chief Executive Officer of Alps Group Inc. &ldquo;Accreditation
at this level signals to hospitals, research institutions, and partners that our genomic data is globally credible, clinically actionable,
and fit for interrogation across our broader ecosystem. This milestone advances our goal of making world-class genomics a reality for
patients across Southeast Asia.&rdquo;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
be added to the Alps Group Inc email distribution list, please email <U>Alps@kcsa.com</U> with ALPS in the subject line.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>About
Alps Group Inc</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alps
Group Inc is a revenue-generating integrated biotechnology platform headquartered in Malaysia, operating across cell manufacturing, molecular
diagnostics, and clinical delivery. Alps leverages revenue from its commercial businesses to support its clinical pipeline development
with a mission to make advanced precision medicine accessible and affordable across Southeast Asia.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B><IMG SRC="ex99-1_001.jpg" ALT="" STYLE="height: 90px; width: 200px"></B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Forward-Looking
Statements</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certain
statements in this press release may be considered to contain certain &ldquo;forward-looking statements&rdquo; within the meaning of
&ldquo;safe harbor&rdquo; provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified
by words such as: &ldquo;target,&rdquo; &ldquo;believe,&rdquo; &ldquo;expect,&rdquo; &ldquo;will,&rdquo; &ldquo;shall,&rdquo; &ldquo;may,&rdquo;
&ldquo;anticipate,&rdquo; &ldquo;estimate,&rdquo; &ldquo;would,&rdquo; &ldquo;positioned,&rdquo; &ldquo;future,&rdquo; &ldquo;forecast,&rdquo;
&ldquo;intend,&rdquo; &ldquo;plan,&rdquo; &ldquo;project&rdquo; and other similar expressions that predict or indicate future events
or trends or that are not statements of historical matters. Forward-looking statements are neither historical facts nor assurances of
future performance. Instead, they are based only on the Company management&rsquo;s current beliefs, expectations, and assumptions. Because
forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that
are difficult to predict and many of which are outside of our control. Actual results and outcomes may differ materially from those indicated
in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
further list and description of risks and uncertainties can be found in documents filed with the Securities and Exchange Commission (&ldquo;SEC&rdquo;)
by the Company and other documents that we may file or furnish with the SEC, which you are encouraged to read. Any forward-looking statement
made by us in this press release is based only on information currently available to the Company and speaks only as of the date on which
it is made. The Company undertakes no obligation to publicly update any forward-looking statement, whether written or oral, that may
be made from time to time, whether as a result of new information, future developments, or otherwise, except as required by law.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Investor
Relations Contact</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Philip
Carlson</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KCSA
Strategic Communications</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone:
212.896.1233</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:
<U>Alps@kcsa.com</U></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex99-1_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ex99-1_001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" #@ ?$# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MQ-C/L1T(]CQ7%B\LIXOWX>[+\'Z_YG;A<PGAO<EK'\O0^\**\[^#/Q03XBZ
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MLWSR.<)$#@GU/TK%B^)VG2+DV]PI]/E_QKHC0JSCS1CH82KTX2Y9/4[&N/\
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M3WY\D8]<'YC^ KM>(IT5S5))+S.7V%2L[4XMOR/ M1@X;BN3U2WZ\5]TZ/\
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M*B_:G_Z&>]_\'@_^*H_X5%^U/_T,][_X/!_\57W3N'J*-P]13_MZM_SYI_\
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M?SK\NA!U)*"W>A^A3DH1<GT/G']HC]M\>"]9N_#7@>&WOM0MF,5UJLXWQ12
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MDFK?]!*Z_P"_S?XU^G?_  Q[\)/^A33_ ,"Y_P#XNC_ACWX2?]"FG_@7/_\
M%T?ZRX+^27W+_,/[!Q?\Z^]_Y'YB?\))JW_02NO^_P W^-'_  DFK?\ 02NO
M^_S?XU^G?_#'OPD_Z%-/_ N?_P"+H_X8]^$G_0II_P"!<_\ \71_K+@OY)?<
MO\P_L'%_SK[W_D?F)_PDFK?]!*Z_[_-_C7W3_P $[[^YO_"'BYKFXEN&6]A
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M?+3EKV>AZ11117C'J!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% '._$+QWI?PU\'ZGXCU>7R[*RB+E0?FD;HJ+_M,< ?6OR5^)?Q!U3XH^
M--3\1ZO)ONKR0L(P25B0<+&OLHP/UZFO<?VU?CW_ ,+'\7_\(MH]SO\ #NBR
M%7>,_+=7(X9_=5Y5?^!'N*\6^%'PVU+XL^.M,\-Z8N);J3,LQ&5@B'+R-[ ?
MF<#O7ZADF C@,.\57TE)7]([_P#!9^?9MC)8RNL/1U2=O5_UHCWW]AOX#?\
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M=_X2K1/^@Q8?^!2?XU4U'XA>%M(@>>]\2:3:Q(,L\U[&H'YM7XV[CZTH9R,
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M_52A02H?(.#P<''ZD>"?&&F?$'P?HOB;19_M.D:Q9Q7UI+TW12(&4GT.#TH
MVZ**_-3_ (*0?\% _'_[/_QFTOP5\-M0LK3['IJ7>K-<V4=QF65LQI\P.T!
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M--W9O&,8+EBK(_5OQ3X.T3QOIJZ?K^EVNKV2R"58+N,.@< @-@]\$_G7)_\
M#.OPR_Z$;1/_  #6O /V/=;_ &M-2^).HQ_';3+*R\)#2Y&MGMX[-6-WYL>P
M9A8MC9YO7CI7V)6L,16IKEA-I>39G*C2F[SBF_0I:-HMAX=TNVTW3+2*QL+9
M=D-O NU(U] .U7:_,_\ :9_:N_:1M/VT=;^#WP>N-/O"EM!/9:=/8VQ<C[(D
MTI,LN!_>/)]A4N@^*O\ @HD^N:<NI:#I:Z<;F,7+"'3.(MPWGA\_=STYK%MR
M=V:I)*R/TKHHHI#"BBN!^//Q;L?@1\'O%?CW48&N[;0[)K@6R-M,TA(2.//;
M<[*N>V<T =]17Y.:%\<?V\/C'X)G^+/A.UT^R\'D2W-IIUM;6@\Z%"V[RXI<
MRR 8(R3EL<9K[$_8 _:\G_:X^$MYJ6L65OI_BS0[E;+5(K3(AEW+NCF1225#
M ,"N3@JV.,4 ?3]%%?!'[9O[<_COPY\8K'X'_ C18];^(4P0WUX\(G^S,R[U
MBC0G;N"8=W?Y5!''4@ ^N]3^ _P\UG4+F_OO!NCW5Y<R-+-/+:J6D=CEF)[D
MDDU6_P"&=?AE_P!"+H?_ (!K7YUQ_MF_M0_L>_$7P[:_M#Z1#J_@[69-K7,4
M5N61<C>T,UO\I= 03&_4=,9S7ZHZ??V^JV%M>V<RW%I<Q+-#,ARKHP!5A[$$
M&NI8K$)651_>SG>'HO5P7W(X+_AG7X9?]"+H?_@&M'_#.OPR_P"A%T/_ , U
MK@/V]/C%XG^ O[,?B;QIX/NH;/7[&>S2&:X@69 )+F.-\HW!^5C71_LA?$C7
M?B]^S9X"\8^)KB*ZUW5[$SW<T,*Q(S>:Z\*O X4=*?UO$?\ /R7WL7U:A_(O
MN1N?\,Z_#+_H1=#_ / -:/\ AG7X9?\ 0BZ'_P" :UK?&+Q'?>#_ (1^-]>T
MN1(M3TO0[Z^M9)$#JLL5N[H2IX(#*..]?EQ\&?VG_P!NK]H#PM/XC\"0:5K>
MCPW+6;W LK"'$JJK%<2%3T9><=Z/K>(_Y^2^]A]6H?R+[D?IC_PSK\,O^A%T
M/_P#6IK;]G_X;6<HDB\#:$KCHQL4/\Q7@O[&^M?M5:GXWUM/CUIMG9>'5T_-
M@UO':*QN?,7C]RQ.-F[KQ7US2>*Q#WJ2^]C6'HK:"^Y%#2= TS08C%IFG6FG
M1'JEI L0/X*!5^OS7_:J_P""A/CK]G']MRV\)375K/\ #.V%A)J%C]B0S^3+
M&#*RRXW;EW%@,]L5]!?\% ?VAO$OP-_9F@\>?#S4[2.^N-1LXX+R2!+F*2WE
M5VRH;(.0%(-<S;;NS=))61]345QWP;\27_C'X1>"-?U21)M3U31+*]NI(T"*
MTLD".Y"C@ LQX[5T/B'7K#PKH.HZUJMREGIFG6TEW=7$APL42*6=C] ":0S0
MHK\K(_VOOVK?VQ/%6OW/[/V@PZ%X'TF8Q1W$\=LLDN.5$DUP=ID8$'RT'R@C
M.>I]@_84_;F\;_$GXH:W\&?C/I,>E?$/34D>"X2 6[3F/F2&6,?*'"G>K)\K
M*#QT) /O.BBOS[_X*$_M4_&;X.?'CX>> _A1>623^)K%!'9W-E#,TUT]RT2
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5SAW@$BAMA8 9(SUQ0!U]%%% '__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
